Brought to you by 
SymBio raises $14.5mm in Series B round
15 Aug 2006
Executive Summary
SymBio (oncology, hematology, and autoimmune disease therapeutics) raised $14.5mm (Y1.66bn) in the first closing of a two-tranche private placement that should eventually bring the company $17.4mm. JAFCO led the round and was joined by returning Series A investors.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
SymBio raises $14.5mm in Series B round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice